A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Archives of Ophthalmology

Volumn 119, Issue 10, 2001, Pages 1417-1436

  Kassoff, A ^a   Kassoff, J ^a   Buehler, J ^a   Eglow, M ^a   Kaufman, F ^a   Mehu, M ^a   Kieval, S ^a   Mairs, M ^a   Graig, B ^a   Quattrocchi, A ^a   Jones, D ^a   Locatelli, J ^a   Ruby, A ^a   Capon A , Jr ^a   Garretson, B ^a   Hassan, T ^a   Trese, M T ^a   Williams, G A ^a   Regan, V ^a   Manatrey, P ^a   Streasick, P ^a   Szydlowski, L ^a   McIver, F ^a   Bridges, C ^a   Stanley, C ^a   Cumming, K ^a   Lewis, B ^a   Zajechowski, M ^a   Margherio, R R ^a   Cox, M S ^a   Werner, J C ^a   Falk, R ^a   Siedlak, P ^a   Neubert, C ^a   Klein, M L ^a   Stout, J T ^a   O'Malley, A ^a   Lauer, A K ^a   Robertson, J E ^a   Wilson, D J ^a   Beardsley, C ^a   Anderson, H ^a   Wallace, P ^a   Smith, G ^a   Howard, S ^a   Dreyer, R F ^a   Ma, C ^a   Chenoweth, R G ^a   Zilis, J D ^a   Johnson, M ^a   Rice, P ^a   Daniel, H ^a   Crider, H ^a   Parker, S ^a   Sherman, K ^a   Martin, D F ^a   Aaberg T M , Sr ^a   Sternberg P , Jr ^a   Curtis, L T ^a   Ju, B ^a   Gilman, J ^a   Myles, B ^a   Strittman, S ^a   Gentry, C ^a   Yi, H ^a   Capone A , Jr ^a   Lambert, M ^a   Meredith, T ^a   Aaberg T M , Jr ^a   Saperstein, D ^a   Lim, J I ^a   Stribling, B ^a   Armiger, D ^a   Swords, R ^a   Orth, D H ^a   Flood, T P ^a   Civantos, J ^a   Debustros, S ^a   Packo, K H ^a   Merrill, P T ^a   Cohen, J A ^a   Figliulo, C ^a   Morrison, C ^a   Bryant, D A ^a   Doherty, D ^a   McVicker, M ^a   Drefcinski, T ^a   Seddon, J M ^a   Pinnolis, M K ^a   Davis, N ^a   Burton, I ^a   Taitsel, T ^a   Walsh, D ^a   Dubois Moran, J ^a   Callahan, C ^a   Evans, C ^a   Snow, K K ^a   Jones Devonish, D A ^a   Crouse, V D ^a   more..

^a EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CENTRUM; CUPRIC OXIDE; PLACEBO; UNCLASSIFIED DRUG; ZINC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUSEN; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

EID: 0034800655     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.10.1417     Document Type: Article

References (51)

1. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity
2. Visual acuity and the causes of visual loss in Australia: The Blue Mountains Eye Study
3. Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study
4. Argon laser photocoagulation for neovascular maculopathy: Five-year results from randomized clinical trials
5. Laser photocoagulation for subfoveal lesions of age-related macular degeneration: Updated findings from two clinical trials
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials: TAP Report 2
7. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy Report 2
8. Drug therapy: Age-related macular degeneration
9. Therapeutic benefits of infrared (810 nm) diode laser macular grid photocoagulation in prophylactic treatment of non-extensive age-related macular degeneration
10. Laser photocoagulation of eyes with drusen: Will it help?
11. Laser treatment in eyes with large drusen: Short term effects in a pilot randomized clinical trial
12. Submacular surgery: New information, more questions
13. Chemistry and metabolism of lipids in the vertebrate retina
14. Review: Antioxidant protection of the ageing macula
15. Solar radiation and age-related macular degeneration
16. The role of oxidative stress in the pathogenesis of age-related macular degeneration
17. Dietary carotenoids, vitamins A, C, and E and advanced age-related macular degeneration
18. Antioxidant status and neovascular age-related macular degeneration
19. Factors associated with age-related macular degeneration: An analysis of data from the First National Health and Nutrition Examination Survey
20. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study
21. A prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy
22. Are antioxidants or supplements protective for age-related macular degeneration?
23. Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study
24. Vitamins, minerals and macular degeneration: Promising but unproven hypotheses
25. Prospective study of zinc intake and the risk of age-related macular degeneration
26. Oral zinc in macular degeneration
27. Six-year supplementation with alpha tocopherol and beta-carotene and age-related maculopathy
28. Oral zinc and the second eye in age-related macular degeneration
29. Editorial. Do we have a nutritional treatment for age-related cataract or macular degeneration?
30. The Age-Related Eye Disease Study (AREDS) design implications AREDS Report No. 1
31. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration
32. The Age-Related Eye Disease Study (AREDS) system for classifying age-related macular degeneration from stereoscopic color fundus photographs AREDS Report No. 6
33. Ocular exposure to UV- B in sunlight: The Melbourne visual impairment project model
34. Development of the 25-item National Eye Institute visual function questionnaire
35. Prevalence of age-related maculopathy: The Beaver Dam Eye Study
36. What's the relative risk?
37. Implementation of group sequential logrank tests in a maximum duration trial
38. A multiple testing procedure for clinical trials
39. Group sequential methods in the design and analysis of clinical trials
40. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
41. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
42. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91
43. A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9
44. Vitamin E supplementation and age-related maculopathy
45. Preliminary identification of the human macular pigment
46. Risk factors associated with age-related macular degeneration A case-control study in the Age-Related Eye Disease Study: AREDS Report No. 3
47. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins